World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
29250
World Ranking
15487
National Ranking
503

Tarik Asselah publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Tarik Asselah sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 549 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Tarik Asselah D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Tarik Asselah sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Tarik Asselah is affiliated with Université Paris Cité in France and has contributed extensively to the field of medicine with a focus on hepatology and infectious diseases. Their research spans several key areas, including hepatitis B and C virus studies, liver disease diagnosis and treatment, and viral epidemiology.

The scientist's most cited recent publications include:

  • COVID-19: Discovery, diagnostics and drug development (2020), Journal of Hepatology
  • Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study (2023), The Lancet. Gastroenterology & Hepatology
  • Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection (2022), New England Journal of Medicine
  • EASL Clinical Practice Guidelines on hepatitis delta virus (2023), Journal of Hepatology
  • Hepatitis B surface antigen seroclearance: Immune mechanisms, clinical impact, importance for drug development (2020), Journal of Hepatology

Asselah frequently collaborates with other researchers in the field. Regular co-authors include:

  • Fabien Zoulim
  • Pietro Lampertico
  • Stanislas Pol
  • Victor de Lédinghen
  • Marc Bourlière

The scientist has a substantial presence in several specialized publication venues, primarily:

  • Journal of Hepatology
  • Liver International
  • New England Journal of Medicine
  • JHEP Reports
  • Journal of Viral Hepatitis

Within the broader domain of medicine, their work is distributed among the following subfields:

  • Epidemiology
  • Hepatology
  • Infectious Diseases
  • Pharmacology
  • Endocrinology, Diabetes and Metabolism

Asselah's primary research topics focus on:

  • Hepatitis C virus research
  • Hepatitis B Virus studies
  • Liver disease diagnosis and treatment
  • Hepatitis viruses studies and epidemiology
  • Liver disease and transplantation
  • Hepatocellular carcinoma treatment and prognosis
  • HIV/AIDS drug development and treatment

Best Publications

  • Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

    Jordan J. Feld;Ira M. Jacobson;Christophe Hézode;Tarik Asselah

  • Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    Vlad Ratziu;Vlad Ratziu;Stephen A. Harrison;Sven Francque;Pierre Bedossa

  • Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

    Graham R. Foster;Nezam Afdhal;Stuart K. Roberts;Norbert Bräu

  • Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis

    Rami Moucari;Tarik Asselah;Dominique Cazals–Hatem;Hélène Voitot

  • Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients.

    Rami Moucari;Rami Moucari;Vincent Mackiewicz;Olivier Lada;Olivier Lada;Marie-Pierre Ripault;Marie-Pierre Ripault

  • Relationship Between Steatosis, Inflammation, and Fibrosis in Chronic Hepatitis C: A Meta-Analysis of Individual Patient Data

    Gioacchino Leandro;Alessandra Mangia;Jason Hui;Paolo Fabris

  • Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

    Fabrice Carrat;Hélène Fontaine;Céline Dorival;Mélanie Simony

  • Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

    Graham S Cooke;Isabelle Andrieux-Meyer;Tanya L Applegate;Rifat Atun

  • Steatosis in chronic hepatitis C: why does it really matter?

    T Asselah;L Rubbia-Brandt;P Marcellin;F Negro

  • Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

    Stefan Zeuzem;Graham R Foster;Stanley Wang;Armen Asatryan

  • COVID-19: Discovery, diagnostics and drug development.

    Tarik Asselah;David Durantel;Eric Pasmant;George Lau

  • Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis.

    Ana-Carolina Cardoso;Rami Moucari;Claudio Figueiredo-Mendes;Marie-Pierre Ripault

  • Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C

    Sarah Maylin;Sarah Maylin;Michelle Martinot–Peignoux;Michelle Martinot–Peignoux;Rami Moucari;Nathalie Boyer

  • Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues.

    Ivan Bièche;Cèline Narjoz;Tarik Asselah;Sophie Vacher

  • Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

    Christophe Hézode;Tarik Asselah;K Rajender Reddy;Tarek Hassanein

  • CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.

    Vivien Béziat;Vivien Béziat;Vivien Béziat;Olav Dalgard;Tarik Asselah;Philippe Halfon

  • Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients

    W. Ray Kim;Thomas Berg;Tarik Asselah;Robert Flisiak

  • Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

    Ira M. Jacobson;Ira M. Jacobson;Eric Lawitz;Edward J. Gane;Bernard E. Willems

  • Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: The ANRS HCEP-23 study

    Jean-Pierre Zarski;Nathalie Sturm;Jérôme Guechot;Adeline Paris

  • Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis

    Tarik Asselah;Kris V. Kowdley;Neddie Zadeikis;Stanley Wang

Frequent Co-Authors

Patrick Marcellin
Patrick Marcellin Université Paris Cité
Marc Bourlière
Marc Bourlière Hôpital Saint Joseph
Graham R. Foster
Graham R. Foster Queen Mary University of London
Nathalie Boyer
Nathalie Boyer Université Paris Cité
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Dominique Valla
Dominique Valla Université Paris Cité
Edward Gane
Edward Gane Auckland City Hospital
Jean-Pierre Bronowicki
Jean-Pierre Bronowicki University Hospital of Nancy
Peter Ferenci
Peter Ferenci Medical University of Vienna
Christophe Hézode
Christophe Hézode Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA opens doors to a wide range of specialties and professional tracks. For prospective clinicians looking to fast-track their education, the shortest pmhnp program options allow students to become psychiatric mental health nurse practitioners in less time, providing flexible pathways for advancement.

Those interested in healthcare management may consider administration degrees. If affordability is a priority, the cheapest mha programs online deliver essential skills without overwhelming tuition fees. Comparing program costs is crucial—explore the masters in healthcare administration cost to identify the best value while ensuring accreditation and quality.

For nurses aspiring to the highest clinical roles, Doctor of Nursing Practice (DNP) degrees are increasingly accessible via distance learning. Choosing from the best online dnp programs enables working professionals to advance their expertise and leadership from anywhere.

Best Scientists Citing Tarik Asselah

Trending Scientists